SEARCH

SEARCH BY CITATION

References

  • 1
    Chapman RW. The colon and PSC: new liver, new danger? Gut 1998; 43:595596. MEDLINE
  • 2
    Abu-Elmagd KM, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, Demetris AJ, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993; 177:335344. MEDLINE
  • 3
    Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330:18411845. MEDLINE
  • 4
    Hanauer SB, Smith MB. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporine. Am J Gastroenterol 1993; 88:646649. MEDLINE
  • 5
    Present DH, Lichtiger S. Efficacy of cyclosporine in treatment of fistulae of Crohn's disease. Dig Dis Sci 1994; 39:374380. MEDLINE
  • 6
    Ierardi E, Principi M, Rendina M, Francavilla R, Ingrosso M, Pisani A, Amoruso A, et al. Oral tacrolimus (FK 506) in Crohn's disease complicated by fistulae of the perineum. J Clin Gastroenterol 2000; 30:200202. MEDLINE
  • 7
    Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ. Combination therapy with oral Tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae. Inflamm Bowel Dis 1999; 5:239245. MEDLINE
  • 8
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Am J Gastroenterol 1998; 93:18601866. MEDLINE
    Direct Link:
  • 9
    Cottone M, Pietrosi G, Martorana G, Casa A, Pecoraro G, Oliva L, Orlando A, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001; 96:773775. MEDLINE
    Direct Link:
  • 10
    Gavaler JS, Delemos B, Belle SH, Heyl AE, Tarter RE, Starzl TE, Gavaler C, et al. Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis. Dig Dis Sci 1991; 36:321328. MEDLINE
  • 11
    Stephens J, Goldstein R, Crippin J, Husberg B, Holman M, Gonwa TA, Klintmalm G. Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. Transplant Proc 1993; 25:11221123. MEDLINE
  • 12
    Shaked A, Colonna JO, Goldstein L, Busuttil RW. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 1992; 215:598605. MEDLINE
  • 13
    Narumi S, Roberts JP, Emond JC, Lake J, Ascher NL. Liver transplantation for sclerosing cholangitis. Hepatology 1995; 22:451457. MEDLINE
  • 14
    Papatheodoridis GV, Hamilton M, Mistry PK, Davidson B, Rolles K, Burroughs AK. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut 1998; 43:639644. MEDLINE
  • 15
    Miki C, Harrison JD, Gunson BK, Buckels JA, McMaster P, Mayer AD. Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation. Br J Surg 1995; 82:11141117. MEDLINE
  • 16
    Befeler AS, Lissoos TW, Schiano TD, Conjeevaram H, Dasgupta KA, Millis JM, Newell KA, et al. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation 1998; 65:393396. MEDLINE
  • 17
    Knechtle SJ, D'Alessandro AM, Harms BA, Pirsch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995; 118:615619. MEDLINE
  • 18
    Loftus EV Jr, Aguilar HI, Sandborn WJ, Tremaine WJ, Krom RA, Zinsmeister AR, Graziadei IW, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998; 27:685690. MEDLINE
  • 19
    Bleday R, Lee E, Jessurun J, Heine J, Wong WD. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36:908912. MEDLINE
  • 20
    Higashi H, Yanaga K, Marsh JW, Tzakis A, Kakizoe S, Starzl TE. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990; 11:47780. MEDLINE
  • 21
    Sahai H, Khurshid A. Statistics in Epidemiology. Methods, Techniques, and Applications. New York: CRC Press, 1996.
  • 22
    Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, Kowdley KV, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110:331338. MEDLINE
  • 23
    D'Haens GR, Lashner BA, Hanauer SB. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 1993; 88:11741178. MEDLINE
  • 24
    Greenstein AJ, Sachar DB, Smith H, Pucillo A, Papatestas AE, Kreel I, Geller SA, et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979; 77:290294. MEDLINE
  • 25
    Katzka I, Brody RS, Morris E, Katz S. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice. Gastroenterology 1983; 85:2229. MEDLINE
  • 26
    Papatheodoridis GV, Hamilton M, Rolles K, Burroughs AK. Liver transplantation and inflammatory bowel disease. J Hepatol 1998; 28; 10701076. MEDLINE
  • 27
    Rennick DM, Fort MM. Lessons from genetically engineered animal models XII. IL-10-deficient (IL-10−/−) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2000; 278:G829G833. MEDLINE